Continuing HIV therapy in the ICU
The risks and benefits of stopping antiretroviral therapy in patients admitted to the ICU are largely unmeasured. In many cases therapy has to be stopped, as parenteral preparations are unavailable for all but one of the antiretroviral agents. Stopping treatment suddenly may be associated with incre...
Kaydedildi:
| Yayımlandı: | Crit Care |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2001
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC137283/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11737898/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cc1040 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|